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Modeling the Binding Sites of Anti-Hen Egg White Lysozyme
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Basis of Antibody Cross-Reactivity and Speciﬁcity
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Structural Biophysics Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland
ABSTRACT Three antibodies, HyHEL-8 (HH8), HyHEL-10 (HH10), and HyHEL-26 (HH26) are speciﬁc for the same epitope
on hen egg white lysozyme (HEL), and share[90% sequence homology. Their afﬁnities vary by several orders of magnitude,
and among the three antibodies, HH8 is the most cross-reactive with kinetics of binding that are relatively invariable compared
to HH26, which is highly speciﬁc and has quite variable kinetics. To investigate structural correlates of these functional
variations, the Fv regions of HH8 and HH26 were homology-modeled using the x-ray structure of the well-characterized HH10-
HEL complex as template. The binding site of HH26 is most charged, least hydrophobic, and has the greatest number of
intramolecular salt bridges, whereas that of HH8 is the least charged, most hydrophobic and has the fewest intramolecular salt
bridges. The modeled HH26-HEL structure predicts the recently determined x-ray structure of HH26, (Li et al., 2003, Nat. Struct.
Biol. 10:482–488) with a root-mean-square deviation of 1.03 A˚. It is likely that the binding site of HH26 is rendered rigid by
a network of intramolecular salt bridges whereas that of HH8 is ﬂexible due to their absence. HH26 also has the most
intermolecular contacts with the antigen whereas HH8 has the least. HH10 has these properties intermediate to HH8 and HH26.
The structurally rigid binding site with numerous speciﬁc contacts bestows speciﬁcity on HH26 whereas the ﬂexible binding site
with correspondingly fewer contacts enables HH8 to be cross-reactive. Results suggest that afﬁnity maturation may select for
high afﬁnity antibodies with either ‘‘lock-and-key’’ preconﬁgured binding sites, or ‘‘preconﬁgured ﬂexibility’’ by modulating
combining site ﬂexibility.
INTRODUCTION
Antibody-antigen complexes, including antibodies against
hen egg white lysozyme (HEL), and in particular the
antibody HyHEL-10 (HH10), have long served as model
systems for understanding the general principles that govern
molecular recognition in protein-protein complexes (Davies
et al., 1988; Bentley, 1996, 1989; Wilson et al., 1991;
Novotny and Sharp, 1992; Kam-Morgan et al., 1993; Smith-
Gill, 1996, 1994; Walls and Sternberg, 1992; Essen and
Skerra, 1994; Neri et al., 1995; Tsumoto et al., 1996; Shick
et al., 1997; Pons et al., 1999; Bahar et al., 1999; Rajpal et al.,
1998). The sequences of thousands of antibodies of the IgG
class have been determined (Kabat et al., 1991). However,
the three-dimensional structures of only a small subset of
sequenced antibodies have been determined by x-ray
crystallography, but several have been homology-modeled
(Anchin et al., 1991; Bassolino-Klimas et al., 1992; Mas
et al., 1992; Tanner et al., 1992; Barry et al., 1994; Orlandini
et al., 1994; Tenette-Souaille and Smith, 1998; Tenette et al.,
1996).
Six b-turns, three each from the heavy and light chains that
form the antigen-combining site, i.e., the complementarity-
determining regions (CDRs) of the IgG, are referred to as L1,
L2, L3, and H1, H2, H3, respectively. The high variability of
the amino-acid sequences of these loops is the source of the
vast diversity in antigen speciﬁcity, but is also the hurdle in
homology-modeling their structures. However, these have
been shown to adopt structures that can be classiﬁed into sets
of ‘‘canonical structures’’ (Conte et al., 1999; Chothia et al.,
1989; Chothia and Lesk, 1987; Al-Lazikani et al., 1997). The
most variable of them,H3, has not been classiﬁed yet due to its
high degree of structural diversity.
The antibodies HyHEL-8 (HH8) and HyHEL-26 (HH26)
share [90% sequence homology with the structurally
deﬁned HH10 (see Padlan et al., 1989; Lavoie et al., 1999;
and this article, Fig. 1). The three antibodies utilize the same
Vk germ-line gene; heavy chains HH10 and HH26 use the
same germ-line gene, whereas that of HH8 is a different gene
of the same VH family (Lavoie et al., 1999; Smith-Gill et al.,
1987). We have shown previously that all three antibodies
recognize coincident (essentially identical to that of HH10)
epitopes on HEL (see Lavoie et al., 1999, 1992; and this
article, Table 1). Among the three antibodies, HH8 is the
most cross-reactive, with kinetics of binding that are
relatively invariable compared to HH26, which is highly
speciﬁc and has quite variable kinetics (Lavoie et al., 1999,
1992; Li et al., 2001). Their distinct functional behaviors
(Table 1), despite their very high degree of sequence identity,
makes this set of antibodies ideal for analysis of the structural
parameters that underlie their functional differences.
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We describe here the homology-modeled three-dimen-
sional structures ofHH8 andHH26 complexeswithHEL. The
recently reﬁned x-ray structures of a fourth antibody in the
same family, HH63 (Li et al., 2000), as well as those of HH26
and a recombinant antibody H8L10 (Li et al., 2003),
complexed with HEL, show that the complexes are all very
similar in structure to each other and to that of HH10,
validating the approach of homology-modeling for these
complexes. Based on detailed analyses of their molecular
structures and interactions, we present a hypothesis for the
structural bases of their ﬁne speciﬁcity and cross-reactivity
differences. The x-ray crystallographic structure of the HH26
complex is now available for evaluation of the homology
model, but it is unlikely that a high resolution structure of the
H8-HEL complex will be forthcoming (Li et al., 2003).
Therefore, thesemodels provide a valuable tool for comparing
the structure-function relationships in these antibodies.
MATERIALS AND METHODS
Overall strategy
The structures of all loops, except H3, were modeled using the coordinates
of Fab10-HEL complex structure (PDB 3HFM; Padlan et al., 1989) as
template. The coordinates of higher resolution of scFv10-HEL complex
(PDB 1c08) were not used because scFv10-HEL has signiﬁcantly different
kinetic and thermodynamic properties from those of Fab10-HEL (Kondo
et al., 1999). On the other hand, because numerous studies from our
laboratory have demonstrated functional equivalence of the Fab antibody to
the IgG antibody, we therefore concluded that the Fab structure would be
FIGURE 1 Sequence comparisons. Heavy- and light-chain amino-acid sequences of HH10 (top row), HH8 (middle row), and HH26 (bottom row).
TABLE 1 Summary of functional characteristics of anti-HEL antibodies HH8, HH10, and HH26
Characteristic HH8 HH10 HH26 Reference
Stage of immune response Hyperimmune Hyperimmune Secondary Ab Mallett et al. (1989); Lipschultz et al. (2000)
‘‘Hot spot’’ residues in HEL
epitope (top 5)*
K97, Y20, G16,
W63, D101
K97, Y20, G16,
R21, N93
K97, Y20, W63,
D101, R21
Kam-Morgan et al. (1993), Li et al. (2001); Pons et al.
(1999); and Smith-Gill lab (unpublished data)
Afﬁnity (KA,108M1)
(HEL, 258C)
232 43.9 1.50 Lavoie et al. (1992, 1999); Li et al. (2001)
Relative decrease in afﬁnity
caused by Ag mutations
Low
(DDG ¼ 0–2)y
Moderate
(DDG ¼ 0.1–4)
High
(DDG ¼ 0.2–51)
Smith-Gill et al. (1984), (1987); Lavoie et al.
(1990, 1999)
Relative cross-reactivity with
mutant Ag
High Moderate Low Lavoie et al. (1989, 1990, 1999)
Apparent kon
(105Ms1) (HEL, 258C)
1.9 2.3 0.09 Lavoie et al. (1999)
Relative decrease in net
kon caused by Ag mutations
Low Low High Lavoie et al. (1999); Li et al. (2001)
Apparent koff
(104s1) (HEL, 258C)
0.2 0.5 4.9 Lavoie et al. (1999)
Relative decrease in net koff
caused by Ag mutations
Low High High Lavoie et al. (1999)
Binding kinetics 2-step 2-step 2-step Lipschultz et al. (2000); Li et al. (2001);
Mohan and Willson (unpublished data)
Rate limiting step of
association
Encounter Encounter Encounter/
docking
Lipschultz et al. (2000); Li et al. (2001)
Association step most
affected by epitope mutations
Both, but minimally Docking Encounter Li et al. (2001); Sinha et al. (2002); and
Smith-Gill lab (unpublished data)
DG of association (kcal/mol)
(HEL, 258C)
13.6 13.1 10.5 Lavoie et al. (1992), 1999; Li et al. (2001)
Percent of free energy from
docking(HEL, 258C)
23% 15% 8% Lipschultz et al. (2000); Li et al. (2001); and
Smith-Gill lab (unpublished data)
Relative thermodynamic
nature of association
Most entropically driven Intermediate Most enthalpically
driven
Mohan and Willson (unpublished data)
*Residues contributing the most free energy of binding determined by alanine scanning; alanine mutants of these residues all lost at least 1 kcal/mol
compared to binding by respective Ab to unmutated HEL. Order of listing reﬂects commonality, not magnitude of energy loss.
yRange of energy loss (kcal/mol) caused by alanine mutants of epitope contact residues.
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a more biologically realistic template for the other antibodies. The
conformational space has been sampled to model H3. Available structures
of the related antibody complex H63-HEL (Li et al., 2000) and the recently
determined structures of HH26-HEL and H8L10-HEL (Li et al., 2003)
support epitope mapping results (Li et al., 2001; Lavoie et al., 1999; Smith-
Gill et al., 1984), suggesting that the orientation of these antibodies to the
lysozyme epitope are essentially identical. Hence, the complexes have been
modeled with this assumption, with the antibodies docked to HEL
identically as HH10. Only the Fv portions of the antibodies were modeled.
Modeling the complete structure of the complexes involved the following
steps:
1. Minimization of the HH10 template structure.
2. Starting with template, framework residues were ﬁrst mutated to either
HH8 or HH26 consensus sequence.
3. Mutations in CDRs L1, L2, L3, H1, and H2 of both HH8 and HH26
were homology-modeled using the program LOOK (Molecular
Applications Group, Palo Alto, CA).
4. Models were utilized to further model H3 of the respective antibodies,
using the program ICM (Molsoft LLC, Metuchan, NJ).
The program LOOK, Vers. 3.0, was used for the purposes of 1),
minimizing the template structure by optimizing the packing interactions
through protein side-chain repacking; 2) modeling amino-acid mutations in
the framework of template structure to sequences corresponding to either
HH8 or HH26; and 3), to mutate and optimize the packing interaction of the
side chains of the CDRs. The module Model Mutant, which is based on the
algorithmCARA (Lee and Levitt, 1991; Lee and Subbiah, 1991), was used to
mutate the framework. ThemoduleModelHomology, based on the algorithm
SEGMOD (Levitt, 1992, 1983), was used for tasks (1) and (3) (see above).
The loop-modeling algorithm in the program ICM (Molsoft, La Jolla, CA),
Vers. 2.7, was used alone to model CDR H3 of both HH8 and HH26. The
procedure samples the conformational space of backbone and side chains,
using a biased-probabilityMonte Carlo search method (Abagyan and Totrov,
1994), and globally optimizes the energy function consisting of ECEPP/3 and
solvation energy terms. All residues of H3 as well as those within a radius of
5 A˚ of this loop were searched whereas the rest were constrained.
Numbering of residues and CDRs are according to Kabat et al. (1991).
Loops that have sequences identical to template were assigned the same
backbone conformations as that of the template. For those with identical
lengths but different sequences, the template sequence and conformation was
initially adopted, upon which ‘‘mutations’’ were carried out using the Model
Homology module of the program LOOK, permitting for backbone confor-
mational changes that might be required during the amino-acid substitutions.
The program CHARMM (Brooks et al., 1983), Vers. 24, was used for all
minimizations. All-atom force-ﬁeld set PARAM20.0 was used to assign
atomic charges and force ﬁelds. A nonbonded cutoff of 9 A˚ was used with
a shifted potential and force-smoothing function. Constant dielectric is used.
Either Adopted Basis Newton-Raphson method or steepest-descent minimi-
zation algorithms were used for all energy minimizations. The program
QUANTA 97 (MSI, San Diego, CA) was used for all other visualizations,
calculating hydrogen bonds, nonbonded contacts, contact areas, and for
generating most of the pictures. A distance of 4 A˚ cutoff was used to cal-
culate nonbonded interactions and a probe radius of 1.4 A˚ used to calculate
solvent-accessible surface and contact areas.
Minimization of template structure
Hydrogens were ﬁxed to the x-ray structure and minimized for 100 ABNR
steps (using CHARMM) to relieve any short contacts caused by ﬁxing of the
hydrogen atoms. This structurewas imported into LOOKand a ‘‘copy’’ of the
sequence of each chain was made, which is identiﬁed as a different molecule.
This ‘‘copy’’ was then homology-modeled, using module ‘‘Model Homol-
ogy,’’ with the original x-ray structure as the template to predict side-chain
conformations. Hence, the backbone and side-chain positions of the ‘‘copy’’
are adjusted to settle in positions for optimal side-chain packing interactions.
Modeling of HH8/HH10-Japanese quail
lysozyme complex
The x-ray structure of Japanese quail lysozyme (JQL) (PDB code: 2IHL)
was overlaid on HEL of HH10-HEL (minimized template) complex for best
root-mean-square (RMS) ﬁt. Coordinates of JQL and HH10 from this
procedure was used to generate HH10-JQL complex. The same was done
with HH8-HEL complex to obtain HH8-JQL complex.
RESULTS
Comparison of Fv region sequences of HH8 and
HH26 with HH10
The Fv segment of HH8 has ;92% sequence identity with
HH10 (Fig. 1) with all corresponding CDRs of identical
length. (Note that, although only the Fv segments of the
antibodies were modeled here, the word antibody is used in
the text to denote these models and their complexes.) Five
substitutions are found in light chain, of which the only CDR
mutation, S93VKN, is in L3, and the rest are in framework
regions. The H chain of HH8 has 13 substitutions relative to
HH10, of which ﬁve are in CDRs. Most of the differences are
in H2, where four substitutions are found (V51VHI, Y53VHF,
S56VHN, and Y58VHF). A single substitution is found in
H3(D101VHT). The notable framework substitutions are
K49VKT, G49VHE, and T30VHI. Overall, three CDRs (L1,
L2, and H1) are identical with the template.
The Fv segment of HH26 has ;94% sequence identity
with HH10 (Fig. 1), with 10 amino-acid differences in the H
chain and only three in the L chain, with all corresponding
CDRs of H26 and H10 of identical length. Of the 10 H chain
differences, only three are in CDRs (H2: V51VHI; H3:
d D96VHE; and G100VHM), and a notable N94VHR frame-
work mutation. Arginine is found in this position pre-
dominantly (Chothia and Lesk, 1987). One of the L chain
substitution is in L1 (G30VKS) and the rest are in framework
regions. Four CDRs (L1, L2, L3, and H1) of HH26 are
identical with those of template.
Minimization of template structure
The positions of side-chain atoms beyond the Cb atom are
not quite reliable in template HH10 complex (PDB 3HFM),
solved at 3.0 A˚ resolution of Padlan et al. (1989). Hence, the
structure was minimized for energy by optimizing the
packing of side chains as detailed in Methods. This
procedure, although not a substitute for a higher-resolution
crystal structure, eliminated certain bad contacts and large
torsion strains present in the x-ray structure. Total energy of
the repacked system is4970 kcal/mole compared to4267
kcal/mole of the x-ray structure, with substantial difference
in the van der Waals component (647 kcal/mole, compared
to 256 kcal/mole of the x-ray structure). The repacked
structure has an RMS difference of 1.04 A˚ with respect to
x-ray structure, with L1 exhibiting the maximum difference
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(1.39 A˚). A likely reason for this is the change in the
backbone dihedral angles (F, C) of G30VK from [79.8,
119], found in x-ray structure, to [58,66] in the repacked
structure. All the intermolecular nonbonded contacts that
were observed in the x-ray structure have been maintained
after the repacking.
Modeling of the hypervariable loops
With the exception of H3, all the CDRs were modeled based
on the canonical-structures hypothesis (Chothia et al., 1989;
Chothia and Lesk, 1987). The four homologous substitutions
of CDR-H2 of HH8 were modeled with the program LOOK,
as described in Methods. Finally, CDR-H3 of both HH8 and
HH26 were modeled using the biased-probability Monte
Carlo method (Abagyan and Totrov, 1994) incorporated in
the program ICM. The individual steps are described in the
following sections.
Models of HH8 loops L1, L2, L3, and H1
The sequences of CDRs L1, L2, and H1 are identical to those
of HH10 (Fig. 1). L3 has one homologous substitution
(S93VHN). CDRs with identical lengths and same critical
residues assume canonical structures (Chothia and Lesk,
1987; Anchin et al., 1991; Bassolino-Klimas et al., 1992;
Mas et al., 1992; Tanner et al., 1992; Orlandini et al., 1994;
Tenette-Souaille and Smith, 1998; Tenette et al., 1996).
Therefore the backbone conformations of CDRs L1, L2, L3,
and H1 are assumed to be the same as that of the template.
Backbone rearrangement to accommodate the S93VHN
mutation was modeled using the Model Homology module
of the program LOOK (see Methods). Stereoviews of the
overlays of the energy-minimized loop models with those of
HH10 CDRs are shown in Fig. 2. RMS difference of the
CDRs L1, L2, L3, and H1 with respect to the template,
considering only Ca atoms, are 0.7 A˚, 0.47 A˚, 0.54 A˚, and
0.4 A˚. L1, L2, L3, and H1 have been reported to belong to
the canonical classes 2, 1, 1, and 19, respectively.
Model of HH8 loop H2
Template CDR-H2 was appropriately mutated to those found
in HH8, then modeled as a homology protein using the
program LOOK. H2 has four mutations compared to HH10
(Fig. 1), with different side-chain volumes and hydrogen-
bonding capacities that could inﬂuence backbone confor-
mation. The residue 71VH has been noted to have an effect on
the conformation of this CDR (Tramontano and Lesk, 1992),
and this residue is arginine in all the three antibodies. In
HH10, R71VH interacts with its CDR-H2 residue V51VH,
which is mutated to I51VH in HH8. Therefore, while
modeling this loop, necessary freedom for backbone was
provided to accommodate the differences in these side-chain
volumes.
The ﬁnal H2 model had an RMS of 1.0 A˚ (compared to the
template structure) considering only the backbone atoms,
and 1.5 A˚ when all the atoms where considered. The
substitution I51VHV increases van der Waals interaction with
R71VH, now oriented closer to H2, with more compact
packing with the backbone of G55VH (not shown). The
backbone dihedrals of residues 53VH and 54VH have changed
to [64, 96] and [162, 15] from [54, 157] and [57, 31] ,
respectively, observed in the template. Values x1 and x2 of
substituted residue F53VH are 1808 and 1348, respectively,
and are different from 838 and 858 of the corresponding
residue Y53VH in HH10. Backbone dihedrals angles (F, C)
of F58VH are [130, 95], compared to [110, 125] of
Y58VH in HH10, orienting F58VH slightly away from HEL
(Fig. 3). There is a large 1.7 A˚ positional shift at the Ca atom
of F58VH, compared to the corresponding position of Y58VH.
This loop has been classiﬁed as belonging to canonical class
1 (Al-Lazikani et al., 1997). However, the hydrogen-bonding
pattern of the loop (Al-Lazikani et al., 1997) suggests that
this CDR of both HH8 and HH10 might belong to class 2B.
The three hydrogen bonds between the main chain atoms of
the turn residues 52VH, 55VH, and 56VH (52N-O56, 52O-
N55, and 52O-N56) that characterize the canonical class of
this CDR are also found in these antibodies. This model of
the complex was minimized for energy by 100 steps of
ABNR and was used to model H3 in the next step.
Model of HH8 loop H3
CDR-H3 is deﬁned between the residues 95 and 102,
according to Kabat and co-workers, and could possess
between ﬁve and 15 residues (Wu et al., 1993; Kabat et al.,
1991). D101VHT is the only substitution in this loop relative
to HH10 (Fig. 1). In the HH10-HEL x-ray structure (Padlan
et al., 1989), D101VH does not make any contacts with HEL;
the residue at position 101VH usually makes only minimal
contacts with antigen (MacCallum et al., 1996). In the crystal
structure of the HH10 template, there is an electrostatic
interaction between the residue K49VK and the aspartic-acid
residue at both positions 96VH and 101VH, which might
inﬂuence the conformation of H3. However, in HH8 both the
residues K49VK and D101VH are mutated to threonine,
precluding electrostatic interactions. Hence, it was felt
necessary to model this CDR rather than assuming the same
conformation as the template despite the identity in length.
Modeling was carried out using the biased-probability
Monte Carlo search method, using the program ICM. The
loop H3 of a sugar-binding antibody was recently modeled
using this program and was found to successfully explain the
experimental observations (Miller et al., 1998).
The lowest-energy model of H3 has an RMS difference of
0.7 A˚ (with backbone atoms) fromH3 of HH10, and has quite
a few notable side-chain orientation differences compared to
the template. Residues D96VH and W95VH are more solvent-
exposed than in HH10. The solvent-accessible area of H3 is
3224 Mohan et al.
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44 A˚2. W95VH adopts a different conformation in an earlier
instance when HH10 was used as a template to model anti-
cystacin antibody (Schiweck and Skerra, 1997). The absence
of the electrostatic interactions between D96VH and K49VK,
nowmutated to threonine, could be the reason for the former’s
altered conformation in HH8. Overlay of the structure of this
loop with that of HH10 is shown in Fig. 2.
Models of HH26 loops L1, L2, L3, H1, and H2
The sequences of CDRs L2, L3, and H1 of HH26 are
identical to those of HH10 and hence, template conforma-
tions were adopted for them. L1 and H2 have a single
substitution each, G30VKS and V51VHI, respectively. These
two substitutions were carried out using the Model
Homology module of the program LOOK, where the back-
bone dihedrals were allowed to relax to accommodate any
minor conformational changes that could arise due to the two
substitutions. This model was minimized for energy by 100
steps of ABNR before proceeding to the next step for
modeling CDR-H3.
Model of HH26 loop H3
There are two substitutions in this CDR: D96VHE and
G100VHM. The conformational space of the backbone
dihedrals were searched by the biased-probability Monte
Carlo method described above. The lowest energy structure
yielded from the search had an RMS of 1.5 A˚ with respect to
the template, when all the atoms of H3 were considered
(Table 2).
Final models of HH8 and HH26 Fv regions
Once H3 was ﬁxed, the models were subjected to energy
minimization until the energy gradient was\0.001 kcal/A˚.
FIGURE 2 Comparisons of CDRs of HH8, HH10, and HH26. (a) Overlays of light-chain CDRs of HH8 and HH26 with those of HH10. Stereoviews of light
chain CDR residues of HH8 (dashed lines) and HH26 (thick lines) superposed for best RMS ﬁt on the corresponding HH10 residues (thin lines). The top,
middle, and bottom rows of ﬁgures correspond to L1, L2, and L3 CDRs, respectively. Numbering of residues are according to Kabat et al. (1991). (b) Overlays
of heavy-chain CDRs of HH8 and HH26 with those of HH10. The top, middle, and bottom rows of ﬁgures correspond to H1, H2, and H3 CDRs, respectively.
In H2, ﬂipping of HH8 residues 53VH and 58VH with respect to its corresponding residues in HH10 and HH26 may be observed.
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Backbone atoms were not constrained during this step.
Energy of the minimized model of HH8 was 4913 kcal/
mole, compared to the initial value of 3319 kcal/mole. The
ﬁnal energy of the HH26 model was 4955 kcal/mole
(initial energy ¼ 3363 kcal/mole). Overlays of the ﬁnal
models with the template HH10 are shown in Fig. 4, and
RMS differences of the loops with respect to those of HH10
are shown in Table 2. Both modeled structures had overall
RMSD of \1 A˚ from the H10 structure, whether Ca or
backbone were considered. However, CDR regions of both
the antibodies exhibit signiﬁcant movements. Both anti-
bodies show large (RMS[1 A˚) shifts in CDR-L2 and CDR-
H3 with respect to HH10. L2 of HH26 is tightly packed
against its H3, whereas that of HH8 has very minimal
packing (Fig. 5), with total area of contact between the
residues of L2 and those of H3 in HH26 at 142 A˚2 compared
to 104 A˚2 in HH8. In addition, CDR-L1 and CDR-H2 of H8
showed large shifts. H2 shifts are not unexpected, due to the
number of amino-acid substitutions.
Distribution of charged and hydrophobic
residues in binding sites
The numbers of hydrophobic and charged residues (seen as
brown, blue, and magenta in Fig. 6) vary in each antibody.
Among the three antibodies, HH8 has the most hydrophobic
residues and fewest charged residues. In contrast, HH26 has
the fewest hydrophobic residues and most charged residues.
HH10 ranks between the other two antibodies for both of
these properties. The increased hydrophobicity of HH8
results from its substitutions in its loop H2 as well as the
framework substitutions K49VKT and T30VHI. The sub-
stitution N94VHR renders the binding site of HH26 more
charged.
Intramolecular salt bridges in the Fv region of
HH8, HH10, and HH26
The three Fv vary in the number of intramolecular salt
bridges they contain. In their entire Fv regions, HH8 has the
fewest (two) (Table 3) and HH26 has the most (eight),
whereas HH10 has an intermediate number (ﬁve) (Table 3).
They can be classiﬁed in three different categories, where
both the participating residues of the salt bridge belong to 1),
light chain, i.e., light-light category (l-l) 2); light and heavy
chain, i.e., light-heavy category (l-h); and 3), heavy chain,
i.e., heavy-heavy category (h-h). The two salt bridges found
in HH8 (l-l: R24VK-D70VK and h-h:K64VH-D86VH) are
commonly present in all three antibodies. In both HH10 and
HH26 (but not HH8), framework residue K49VK is involved
in two l-h salt bridges, each with heavy-chain CDR-H3
residues D101VH and D/E96VH HH10 and HH26, respec-
tively. In HH8, residues 49VK and 101VH are both mutated to
threonine, thus precluding the electrostatic interactions
between them, and most likely inﬂuencing the conformation
FIGURE 3 Comparison of CDR-H2 of HH8 and HH10. Stereoviews
showing the overlays of heavy-chain CDR-H2 of HH8 (dashed lines) with
HH10 (thin lines) and their corresponding contact residues of HEL (thick
lines). Residues at positions 53VH and 58VH of HH8 are phenylalanines
(both are tyrosines in HH10), and are ﬂipped away from HEL, with
a substantial backbone conformational change. Due to the change in
orientation of phenylanalanine residues with respect to HEL, CDR-H2 of
HH8 makes very minimal contacts with HEL. The only hydrogen bond that
a H2 residue of HH8 forms with HEL is between N56VH (serine in HH10)
and S100HEL.
TABLE 2 Tabulation of RMS differences of modeled HH8 and
HH26 structures with respect to HH10 template
HH8 HH26
All Ca atoms 0.67 0.57
All backbone atoms 0.76 0.64
CDR 1.36 (0.95)* 1.01 (0.80)
CDR-L1y 1.27 (0.90) 0.90 (0.63)
CDR-L2 1.15 (0.76) 1.76 (1.24)
CDR-L3 0.91 (0.70) 0.70 (0.35)
CDR-H1 0.64 (0.40) 0.42 (0.20)
CDR-H2 1.52 (1.00) 0.60 (0.20)
CDR-H3 1.21 (0.70) 1.52 (1.00)
*RMS differences obtained by superposing all atoms of the backbone as
well those of Ca alone; the later values are shown within parentheses.
yCDRs of heavy and light chain are denoted as H1, H2, H3, and L1, L2,
L3, respectively.
FIGURE 4 Overlays of the entire Ca backbone of HH8, HH10, and
HH26. Stereoviews of superpositions of the Ca traces of HH8 (dashed lines)
and HH26 (thick lines) with HH10 (thin lines). Each CDR is labeled and
their corresponding RMS with respect to HH10 is tabulated in Table 2.
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of CDR-L2 as well. In HH26, the single framework
substitution N94VHR leads to the formation of a network
of three extra salt bridges, all of the h-h category. Two of
these are with residues E96VH and D101VH in H3 and one
with residue D32VH in H1 (Fig. 6). HH8 and HH10 have N at
position 94VH (Fig. 1) and hence they do not have these
interactions. Residue 34VK, a framework residue according
to Chothia numbering and belonging to L1 according to
Kabat numbering (Kabat et al., 1991), is hydrogen-bonded to
D96VH and E96VH of HH10 and HH26, respectively. This is
in addition to the interaction of the later two residues with
K49VK of their respective light chains. Notably, HH8 has the
K49TVK mutation, and consequentially the strong electro-
FIGURE 5 Illustration of packing between CDRs L2 and H3. Stereo
illustrations depicting the packing interactions between the residues of
CDRs L2 and H3 in HH8 (top), HH10 (middle), and HH26 (bottom), CDR
residues alone shown in space-ﬁlling and rest of the atoms as thin-ribbon
representations, respectively. Heavy-chain, light-chain, and HEL are shown
in pink, red, and blue, respectively. Polar and hydrophobic residues of CDR
L2 are shown in cyan and yellow, respectively, whereas most of the CDRH3
residues are in red. HH8 (top) has threonine at both the positions 49Vk and
101VH, shown in red and green, respectively (whereas they are lysines and
aspartic acid, respectively, in both HH10 and HH26), and has hardly any
interaction between its CDRs L2 and H3. K49Vk and D101VH residues of
HH10 (middle) and H26 (bottom) are shown in magenta and green,
respectively. Additionally in HH26, E96VH is also shown in green. HH10
and HH26 have their corresponding CDRs tightly packed due to the
electrostatic interaction between their charged residues in L2 and H3.
Figures prepared using QUANTA 97.
FIGURE 6 Composite ﬁgure of surface representations and intramolec-
ular salt links. In the left panels, the CDR residues alone are shown in
molecular surface representations. Surfaces corresponding to hydrophobic,
polar, positively-charged, and negatively-charged residues are shown in
brown, light blue, dark blue, and magenta, respectively. In the right panels,
molecular ﬁgures depicting the presence and absence of intramolecular
interactions (salt links) are shown. The residues that participate in the
intramolecular salt links in HH10 and HH26 (and those corresponding
that are not involved in salt links in HH8) are shown in space-ﬁlling
representation and the rest of the CDR residues in thin-ribbon representation.
Molecular surface and intramolecular interactions of HH8 are shown in top-
left and top-right panels, respectively; those of HH10 are shown in middle-
left and middle-right, respectively; and those of HH26 are shown in bottom-
left and bottom-right, respectively. HH8 can be seen to have the largest
hydrophobic surface area, whereas HH26 has the largest charged-surface
area. Mutation of the two charged residues at positions 49Vk and 101VH in
HH8 to threonine precludes most of the salt links that are otherwise present
in HH10 and HH26. Substitution of the framework residue at position 94VH
from asparagine to arginine leads to formation of extra salt links in HH26.
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static interaction between this residue and D96VH is lacking.
D96VH is now shifted, precluding an interaction with H34VK.
All the intramolecular salt links present in HH26 are germ-
line encoded, whereas HH8 has eliminated almost all of them
(excepting the two salt links which are commonly present in
all the three antibodies), either by somatic mutations or by
codon encoded by joint mechanism (Table 3, this article; see
also Lavoie et al., 1999, 1992; Li et al., 2001; Smith-Gill
et al., 1987). Half of the salt links present in HH10 are germ-
line encoded, whereas the rest have been eliminated through
joint and somatic mutation mechanisms (Table 3). Electro-
static calculations show that all these intramolecular
interactions contribute to the overall free energy of these
antibodies and their interactions (Sinha et al., 2002).
Intermolecular interactions in the antibody-
antigen complexes
Signiﬁcant functional differences among these three anti-
bodies are correlated with only a limited number of structural
differences (Lavoie et al., 1999) (Tables 3 and 4). The total
antigen contact area of the HH8 binding site is 730 A˚2,
compared to the values of 750 A˚2 and 760 A˚2 for HH10 and
HH26, respectively. The HH8 complex has fewer intermo-
lecular hydrogen bonds than either HH10 or HH26. Heavy-
chain residues participate in fewer hydrogen bonds with
antigen than light-chain residues, mainly due to the
substitution of the two tyrosine residues in H2 to phenyl-
alanines (Fig. 1). Variation in L3 conformation (Fig. 2, Table
2) results in loss of the hydrogen bond between R21HEL and
side-chain Y96VK that is found in HH10-HEL complex.
HH8 also has fewer nonbonded contacts with HEL
compared to HH10 (Fig. 7, Table 5). Again, the substituted
residues Y53VHF and Y58VHF account for most of the
differences (Fig. 3). The van der Waals interaction between
the pair of aromatic residues Y33VH and W63HEL is missing
in this complex. Only one H-chain residue of HH8 contacts
R21HEL, compared to three in HH10 (Padlan et al., 1989). As
in HH10-HEL complex, a solvent-accessible charged in-
teraction is found between D32VH and K97HEL.
TABLE 3 Intramolecular salt links observed in the Fv region of HH8, HH10, and HH26
Salt link HH8 HH10 HH26
R94VH–E96VH 0 N94VH,D96VH 0 N94VH,D96VH 1 R94VH,E96VH
R94VH–D101VH 0 N94VH,T101VH 0 N94VH,D101VH 1 R94VH,D101VH
R94VH–D32VH 0 N94VH,D32VH 0 N94VH,D32VH 1 R94VH,D32VH
K49Vk –D101VH 0 T49Vk,T101VH 1 K49Vk,D101VH 1 K49Vk,D101VH
K49Vk–D96VH 0 T49Vk,D96VH 1 K49Vk,D96VH 1 K49Vk,E96VH
H34Vk–D96VH 0 H34Vk,D96VH 1 H34Vk,D96VH 1 H34Vk,E96VH
R24Vk–D70Vk 1 R24Vk,D70Vk 1 R24Vk,D70Vk 1 R24Vk,D70Vk
K64VH–D86VH 1 K64VH,D86VH 1 K64VH,D86VH 1 K64VH,D86VH
The presence or absence of a given salt link (or ion pair which could participate in electrostatic interactions and/or form a salt link; Sinha et al., 2002) in each
antibody is indicated by a 1 or 0, respectively. Boldface text, germ-line encoded; italic text, D-encoded; underlined italic text, codon encoded by joint;
underlined boldface text, somatic mutation; and normal text, unknown (the germ-line sequence for this VH gene has not been determined).
TABLE 4 Hydrogen bonds between the antibodies and antigen
Lysozyme residue HH8 HH10 HH26
Light-chain residues
Arg14 O Asn31 ND2 Asn31 ND2 Asn31 ND2
Gly16 O Asn32 ND2 Asn32 ND2 Asn32 ND2
Asn93 OD1 Gln53 NE2 Gln53 NE2 Gln53 NE2
Asn93 ND2 Gln53 OE1 Gln53 OE1 Gln53 OE1
Asn19 O Asn92 ND2 Asn92 ND2 Asn92 ND2
Tyr20 OH Tyr96 OH Tyr96 OH Tyr96 OH
Arg21 N Asn92 O Asn92 O Asn92 O
Arg21 NH1 Tyr96 OH Tyr96 OH
Heavy-chain residues
Arg73 NH1 Ser31 OG Thr30 O, Ser31 OG Thr30 O, Ser31 OG
Lys97 NZ Asp32 OD1 Asp32 OD1 Asp32 OD1, Glu96-OE2
Lys97 O Tyr33 OH Tyr33 OH Tyr33 OH
Arg21 NH1 Tyr50 OH Tyr50 OH
Ser100 O Tyr50 OH Tyr50 OH
Asp101 OD1 Asn56 ND2 Tyr53 OH Tyr53 OH
Gly102 N Tyr58 OH Tyr58 OH
Asn77 OD1 Arg94 NH1
Total number of hydrogen bonds 11 16 18
The cutoff distance between the pairs of hydrogen-bonded heavy atoms is 3 A˚.
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To estimate the extent of packing of the CDRs, the total
solvent-accessible surface areas of the CDRs in the absence
of HEL was calculated. The binding site of HH26 is the most
tightly packed, with a smallest solvent-accessible surface
area of 2090 A˚2. The corresponding areas for HH8 and
HH10 are 2215 A˚2 and 2140 A˚2, respectively. There are
more hydrogen bonds between this antibody and HEL than
the other two complexes (Table 4). The increase is a result of
both direct and indirect effects of the framework mutation
N94VHR. Side-chain atom NH1 of R94VH hydrogen bonds to
side-chain atom OD1 of N77HEL. The salt link between
D32VH and K97HEL, found in both HH10-HEL and HH8-
HEL complexes, is also seen here. In addition, HH26 E96VH
is more exposed due to its intramolecular electrostatic
interactions with R94VH and K97HEL. HH26 has almost
twice the heavy-chain-mediated interactions with (28)
compared to HH8 (15).
Modeled complexes of HH8 and HH10 with JQL
The complexes of HH8 and HH10 with Japanese quail
lysozyme (JQL) were modeled (Fig. 8) to enable us to
understand the ﬁne speciﬁcity differences among the three
antibodies to antigen mutations (Li et al., 2001; Lavoie et al.,
1999, 1992; Sinha et al., 2002). JQL is a natural species
variant of HEL with N19K, R21Q, G102V, and N103H
mutations. Due to G102V substitution in JQL (PDB code:
2IHL), there is a large local conformational change in the
backbone at the C-terminal end of helix containing this
(Chitarra et al., 1993). HH8 is able to accommodate the
conformational differences of JQL in two ways (Fig. 8): 1),
F58VH is turned away from the interface and hence avoids
any steric interaction with D101JQL, which has shifted
relative to the position of D101HEL; and 2), it is insensitive to
the loss of hydrogen bond with main chain nitrogen at
position 102JQL due to the substitution of F58YVH. HH10, on
the other hand, is unable to accommodate the structural
changes in epitope. HH10 not only suffers a loss of hydrogen
bond between its residues Y58VH with main chain N of
G102JQL, it probably also encounters a severe strain between
its residues Y58VH and D101JQL. Thus, the higher cross-
reactivity of the high afﬁnity HH8 with JQL is modulated at
least in part by the higher conformational ﬂexibility of the
HH8 combining site. In this case, the conformational
ﬂexibility yields greater plasticity, and cross-reactivity is
achieved while maintaining high afﬁnity for HEL.
DISCUSSION
The three-dimensional structure of the Fv domains of the two
antibodies HH8 and HH26 have been computer-modeled
based on the x-ray structure of the highly homologous
antibody HH10. The ﬁnal structures are within 1.2 A˚ RMS of
each other, with small but signiﬁcant differences in the
conformations of their CDRs. Analyses of the antibodies
themselves as well as their complexes reveal that these
antibodies consistently rank in the same order based on their
various chemical and structural properties. Among the three
antibodies, HH8 has the most hydrophobic and least charged
binding site, whereas HH26 has the least hydrophobic and
most charged binding site. HH10 ranks intermediate to the
two antibodies. Mutations that increase hydrophobic inter-
actions have been hypothesized to be an important
mechanism underlying antibody afﬁnity maturation (Li
et al., 2003). HH8 forms the fewest of hydrogen bonds and
van der Waals contacts with HEL, whereas HH26 forms the
most. HH10 ranks intermediate to the two antibodies. HH8
has the fewest of intramolecular salt bridges whereas HH26
has the most. HH10, once again, ranks between the two. We
hypothesize that the presence (or absence) of germ-line
FIGURE 7 Composite ﬁgure of contact residues in antibodies and antigen,
with ﬁgure showing the contact residues of the antibodies and HEL. All
atoms are shown in space-ﬁlling representations, and those involved in
electrostatic and van der Waals interactions alone are shown in color. In the
left panels, antibodies are shown. Residues belonging to CDRs L1, L2, and
L3 are shown in light blue, cyan, and dark blue, whereas those belonging to
CDRs H1, H2, and H3 are shown in orange, magenta, and red, respectively.
The framework residues at positions 30VH in all antibodies are shown in
green. In right panels, contact residues of HEL are shown; residues contacted
by antibody light-chain residues are shown in red; those contacted by heavy-
chain residues in dark blue; and those by residues of both chains in green.
The top, middle, and bottom panels correspond to HH8-HEL, HH10-HEL,
and HH26-HEL complexes, respectively. HH8 can be seen to have the
fewest contact residues (which are also scattered), whereas HH26 has the
most (and also tightly clustered) contact residues. Correspondingly, the HEL
in complex with HH8 has the fewest contact residues, whereas the one in
contact with HH26 has the most.
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encoded intramolecular salt bridges modulates the ﬂexibility
of the antibody-combining side. These properties are
summarized in Table 6. From comparison of Table 6 with
the functional characteristics in Table 1, it is evident that the
structural and functional characteristics are correlated. The
high speciﬁcity of HH26 is probably mediated by the high
number of hydrogen bonds and van der Waals contacts.
Computational studies agree with these observations: the
HH26 complex exhibits very strong electrostatic interactions,
whereas they are weak in HH8 and intermediate in HH10
(Sinha et al., 2002). In contrast, the cross-reactive behavior of
HH8 is characterized by fewer of these interactions.
Minimization of template
Among the three antibodies that are being discussed here, the
x-ray structure of only HH10 was available at a modest
resolution of 3 A˚ at the time of this study. The variable
region of the template (HH10) differs by only 0.85 A˚ from
the recently available structure of a very similar and related
antibody HyHEL-63, determined at 2.0 A˚ resolution (Li
et al., 2000). The small RMS difference between these two
structures implies that the uncertainty in the structure of
HH10 may not be[0.85 A˚ and hence the HH10-HEL x-ray
structure is an appropriate template. Also, the chemical and
functional properties of HH8, HH10, and HH26 were
consistently correlated among themselves, justifying our
choice of HH10 as the template to model the other two.
Despite the high degree of sequence identity, these three
antibodies exhibit differences in ﬁne speciﬁcity (Table 1).
Since ﬁne speciﬁcity might arise from even minor differ-
ences in conformations of the side chains, it is important that
the positions and conformations of the side chains of the
template are known unambiguously. Optimization of the
template structure for side-chain packing interactions leads
to a signiﬁcant backbone conformational change in L1. This
CDR has been earlier classiﬁed to belong to canonical class 2
(Martin and Thornton, 1996); however, after the repacking,
the backbone dihedral adopts a slightly different conforma-
tion, which now appears closer to canonical class 1 than 2. A
higher resolution structure of the template might help to
resolve the ambiguity in the classiﬁcation of the loops. In
several earlier instances, reﬁnement of a structure at a higher
resolution has led to a revision of classiﬁcation of the
canonical types of its CDRs (Al-Lazikani et al., 1997). In
particular, the conformation of L1 in the structure of
antibody 4-4-20 was found to conform to the predicted
canonical structure after reﬁnement at a higher resolution
(Whitlow et al., 1995), which could be interesting in the
present context. The backbone dihedral angles (F, C) of the
residue Y50VK in the template remains in the disallowed
region of Ramachandran map even after minimization (68,
52; they are 40, 71 before minimization). Such strained
values are also observed in L2 region of the antibody 36-71
(Al-Lazikani et al., 1997).
The x-ray structure of scFvHH10-HEL complex at
a resolution of 2.3 A˚ reveals several side-and main-chain
conformational differences from the structure of FabHH10-
HEL complex (Kondo et al., 1999). One of the most
important backbone differences is found in CDR-H3, where
TABLE 5 Nonbonded interactions between HEL and the three antibodies
HEL residues HH8 HH10 HH26
Light-chain contact residues
K13 S30
R14 N31 N31 N31
H15 N31 N31 N31
G16 G30, N31 G30, N31, N32 S30, N31, N32
N19 N92 N92 N92
Y20 N32, S91, Y96 N32, S91, N92, Y96 S91, N92, Y96
R21 N92,W94,Y96 N92, Y96 S91, N92, W94, Y96
89 Q53 Q53 Q53
N93 Y50 Y50, Q53 Y50, Q53
K96 Y50 N32, Y50 N32, Y50
Heavy-chain contact residues
Y20 W95 W95 W95
R21 Y50 Y50, Y58, W95 Y50, Y58, W95
W62 Y53 Y53
W63 Y33, Y53 Y33, Y53
R73 I30, S31 T30, S31 T30, S31
L75 S31 S31, D32 S31, D32, R94
K97 D32, Y33 D32, Y33, W95 D32, Y33, E96, W95
I98 Y33 Y33 Y33
S100 Y50, W95 Y33, Y50, Y58, W95 Y33, Y50, Y58, W95
D101 Y33, S52, F53, S54 Y33,S52, Y53, S54,S56 Y33, S52, Y53, S54, S56
G102 S56 S56, Y58 S56, Y58
Total 29 (LC ¼ 14 1 HC ¼ 15) 43 (LC ¼ 17 1 HC ¼ 26) 47 (LC ¼ 19 1 HC ¼ 28)
Two residues were considered to be involved in nonbonded interaction if the distance between any two pairs of their atoms were at a distance of #4 A˚.
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the Ca position of residue D96VH has shifted by 2 A˚ toward
HEL and forms a salt bridge with K97HEL. Kondo and co-
workers also ﬁnd differences in the packing of heavy and
light chains against each other, which they mention is
a consequence of the ﬂexibility introduced in the Fv structure
by the absence of stabilizing constant domains. In addition,
there are differences in afﬁnity between the Fab and scFv
complexes (Kondo et al., 1999; Pons et al., 2002). Variations
in the packing of heavy and light chains could also affect
intermolecular contacts (Tramontano and Lesk, 1992).
Hence, the minor differences in intermolecular contacts that
are observed in the structure of this scFvHH10-HEL
complex may be a consequence of this phenomena arising
out of lack of constant domains.
Different antibodies to identical epitopes
It is a well-established fact that antibodies with similar or
completely different sequences can be raised against the
same antigen or even identical epitope (Schmitter et al.,
1990; Goshorn et al., 1991; Kortt et al., 1994; Lescar et al.,
1995). The CDRs of such different antibodies might adopt
quite similar conformations although may not have identical
positions relative to the antigen. A similar phenomena is also
observed in this present study, where the three antibodies, as
well as a fourth antibody for which the structure has recently
been determined (Li et al., 2000), have been shown to
recognize coincident epitopes on HEL (Newman et al., 1992;
Lavoie et al., 1999; Li et al., 2001, 2000). The conformations
of their CDR-H3 are also quite similar. Subtle differences in
their backbone conformations (e.g., CDR-H2 of HH8) likely
play signiﬁcant roles in mediating the speciﬁcity differences
among them. Comparison of the complexed and uncom-
plexed structures of HyHEL-63 shows that CDR-H2 of
HyHEL-63 displays the largest differences in conformation
between the two states (Li et al., 2000), indicative of the
inherent ﬂexibility of this CDR. A detailed comparison of the
HH10-HEL and HH63-HEL structures is described else-
where (Li et al., 2000).
Intramolecular salt bridges
Apart from intermolecular interactions, the charged residues
in the Fv region form several functionally signiﬁcant
intramolecular salt bridges. Intramolecular salt bridges and
hydrogen bonds are known to stabilize protein structures
(Horovitz et al., 1990; Vanhove et al., 1995; Takahashi, 1997;
Elcock, 1998; Sindelar et al., 1998; Sinha and Smith-Gill,
2002b; Sinha et al., 2001a,b). They have also been observed
to have similar roles in antibodies (Parhami-Seren et al.,
TABLE 6 Comparison of structural characteristics of HH8, HH10, and HH26 and their complexes with HEL
Characteristic HH8 HH10 HH26
Antigen contact area (A˚2) 730 750 760
Antibody contact residues 29 43 47
HEL contact residues 18 20 21
Hydrogen bonds with HEL 11 16 18
Intramolecular salt bridges (Fv) 2 5 8
Binding site charges Relatively uncharged Intermediate Highly charged
Binding site hydrophobicity Hydrophobic Intermediate Not hydrophobic
Conformational ﬂexibility Relatively ﬂexible Intermediate Relatively rigid
Binding mode Induced-ﬁt Intermediate Rigid body ‘‘lock-and-key’’
FIGURE 8 Complex of HH8 and HH10 with JQL.
Comparison of the model complexes of HH8 and HH10
with JQL (PDB code: 2IHL) and HEL. The structure of
JQL (thin lines) is superposed on HEL of HH10-HEL
complex (thin dashed lines). HH8 is shown in thick dashed
lines (the HEL in complex with HH8 is not shown for
clarity of picture). The residue at position 101VH of JQL
has a large shift with respect to its corresponding residue in
HEL. HH10 is unable to accommodate this large backbone
change in its epitope because its residue Y58VH would
have a severe steric clash with the residue 101JQL.
However, HH8 can accommodate this large epitope
change, because its heavy-chain residue F58VH and the
backbone atoms in that local stretch have a different
conformation from that of HH10, so as to accommodate
this epitope mutation.
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1993; Miyazaki et al., 1997). Effects of such interactions on
the structure of the binding sites of HH26 and HH8 are quite
evident. HH26, with the most salt bridges, has presumably
a rigid and well-compacted binding site, in contrast to the
presumably ﬂexible binding site of HH8 which has many
fewer salt bridges (Fig. 5). Whereas buried salt bridges de-
stabilize protein structure, those on the surface have a rela-
tively smaller effect on the structure (Schmitt et al., 1999).
Coupled salt bridges forming complex salt-bridge net-
works contribute to the stability and function of proteins
(Horovitz et al., 1990; VanAntwerp and Wittrup, 1998;
Sinha and Smith-Gill, 2002a), connect protein subunits
(VanAntwerp and Wittrup, 1998), and ﬁne-tune the speciﬁc
structure of the functional site (Mummert and Voss, 1996).
The complex salt-bridge networks found in HH10 and HH26
likely play a similar role (Sinha and Smith-Gill, 2002a).
D101VH and K49VK, which participate in the network of salt
bridges in HH10 and HH26, are not completely on the
surface and do not contact the antigen, as can be seen in the
x-ray structure of the template (Padlan, 1990). Both these
residues as well as residues E96VH and R94VH of HH26 are
involved in the formation of the salt-bridge networks
interconnecting the CDRs (Sinha et al., unpublished results).
Short-term molecular dynamics simulations of these com-
plexes show that the mobility of the CDRs directly correlates
with the degree of intramolecular salt bridges networking
them (S. Mohan, unpublished results). This implies that
these salt bridges can play a major role in mediating the
plasticity of the binding site. We hypothesize that these salt
bridges of HH10 and HH26 bestow upon their respective
binding sites important structural features in terms of
providing shape and mediating ﬂexibility. Computational
quantiﬁcation of the energetic contribution of these salt
bridges toward the stability of the antibodies (Sinha et al.,
2001a,b) are consistent with this prediction (Sinha and
Smith-Gill, 2002b).
Determinants of speciﬁcity and cross-reactivity
in antibody-antigen interactions
The type and extent of intermolecular interactions are quite
different in the complexes of these three antibodies with
HEL, and clearly correlate with the types of residues present
in their respective binding sites. Whereas charged residues in
protein-protein interfaces are often responsible for mediating
hydrogen bonds and salt bridges (Xu et al., 1997), charge
interactions themselves serve as direct sources of speciﬁcity
in protein-protein interactions (Conte et al., 1999; Pellecchia
et al., 1999). These three antibodies also conform to this
hypothesis. HH26 with the most charged residues forms the
most hydrogen bonds whereas HH8 has the greatest number
of hydrophobic residues and forms the fewest hydrogen
bonds with HEL. The large number of intermolecular
hydrogen bonds of HH26 is one of the likely sources of its
high speciﬁcity (Conte et al., 1999; DeLano et al., 2000;
Pons et al., 2002). If this is assumed to be true, then a loss of
such interactions when it encounters a mutant antigen should
be reﬂected in a signiﬁcant reduction of association-
enthalpic energy. The corresponding fewer hydrogen bonds
that HH8 forms should result in a smaller loss of enthalpic
energy. Results from isothermal titration calorimetry experi-
ments, performed to measure the association energetics of
these antibodies with HEL and JQL, are very supportive of
these arguments (Mohan et al., 2000). Relative to their
complexes with HEL, the complexes of HH26 and HH8 with
JQL exhibit the largest and smallest loss (changes) of
enthalpic energy, respectively. The enthalpic loss for HH10-
JQL complex is intermediate to the two extremes (Mohan
and Willson, unpublished data). Computational studies
conﬁrm that among the three complexes, HH8-HEL has
the largest hydrophobic contribution to the free energy of
binding, and salt bridges in HH8-HEL pay lower desolvation
penalties than those in HH10-HEL and HH26-HEL com-
plexes (Sinha et al., 2002). Hydrophobic residues in the
interfaces of interacting proteins are believed to mediate
stability of the complex, rather than speciﬁcity (Janin, 1999;
Tsai et al., 1996; Zeder-Lutz et al., 1997; Sinha and Smith-
Gill, 2002b). Consistent with this, among the three anti-
bodies, HH8 complexed with native and mutated HELis
the most stable of the three antibodies, as evidenced by low
kd values and slow observed dissociation rates. A similar
role can be envisioned for the hydrophobic residues present
in the binding site of HH8 when this antibody associates
with HEL and other mutant forms. HH8 is predicted to form
large nonspeciﬁc hydrophobic interactions that could be
a source of both cross-reactivity and afﬁnity (Li et al.,
2003; Sinha et al., 2002; Mohan et al., unpublished results).
Conformational ﬂexibility is also believed to be yet
another source of antibody cross-reactivity (Mian et al.,
1991; Jeffrey et al., 1995; Ditzel et al., 1996; Diaw et al.,
1997; Sinha and Smith-Gill, 2002b). Studies show that both
framework and the CDR regions have a considerable amount
of inherent conformational plasticity (Schulze-Gahmen et al.,
1993; Stanﬁeld et al., 1993; Arevalo et al., 1994; Holmes and
Foote, 1997). However, the structural mechanisms that
mediate such topographical complementarity and other
conformational ﬂexibility are yet to be deﬁned. Here, for
the ﬁrst time, we propose a mechanism by which intra-
molecular salt bridges could play a major role in mediating
such conformational ﬂexibility of the CDRs. The presence of
large number of intramolecular salt bridges in the HH26
renders its CDRs rigid, leading to a ‘‘lock-and-key’’ type of
association and making it less adaptable to mutations in
epitope. Fewer salt bridges in HH8 allow the CDRs to be
more ﬂexible, allowing an induced ﬁt when binding, thus
accommodating changes in the epitope. Computation of the
relative strength of inter- and intramolecular electrostatic
interactions in the three complexes are consistent with this
hypothesis (Sinha et al., 2002).
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Ample experimental evidence supports these arguments.
First, the study of association and dissociation kinetics of
these antibodies with HEL and several mutant lysozymes,
using the surface plasmon resonance technique, indicate
a two-step mode of association, interpreted as an initial
encounter followed by a docking or annealing step that could
include induced ﬁt (Lipschultz et al., 2002, 2000; Li et al.,
2001). The HH8 complex derives the greatest portion of its
free energy of binding from the docking step, whereas the
corresponding gain for HH26 is the least (Mohan et al., 2003,
unpublished results; Li et al., 2001).
Although it is likely that structural rearrangements at the
interface are one of several events that could occur during the
docking phase and inﬂuence the changes in free energy, it
nevertheless correlates quite well with our hypothesis that
HH8 would be the most likely to undergo conformational
rearrangement (due to its ﬂexible binding site), and HH26 to
be the least likely to undergo similar change (due to its rigid
binding site). Second, changes in conﬁgurational entropy, as
measured by ITC, is greatest in the complexes of HH8 with
both HEL and JQL, smallest in those formed by HH26, and
intermediate in those of HH10. This is not possible unless
HH8 exhibits an ability to undergo the greatest conforma-
tional rearrangement during association, albeit at a cost of
large conﬁgurational entropic penalty, reﬂecting its inherent
ﬂexibility (Mohan et al., 2000). The opposite of this situation
is true of HH26. Both these experimental results support the
hypothesis that the three antibodies could exhibit different
degrees of ﬂexibilities.
The retention (as in HH26) or elimination (as in HH8) of
sequences capable of mediating salt bridges during the
process of afﬁnity maturation may well have occurred to
obtain the desired structural feature (of having a ﬂexible or
rigid binding site), and thus has a functional character of
being cross-reactive or speciﬁc. Structural differences among
the binding sites, which are not necessarily mediated by salt
bridges, also have signiﬁcant direct effects on the ability of
these antibodies to cross-react with mutant antigens. This can
be illustrated with the models of the complexes of JQL with
both HH8 and HH10 (Fig. 8). The conformational changes
observed in the CDR-H2 of HH8 as a result of substitution of
uncharged residues, and not due to intramolecular salt
bridges, is an instance where hydrophobic residues are also
likely mediators of cross-reactivity.
Since this study was completed, x-ray crystal structures of
HyHEL26 and the chimeric antibody H8L10 complexed
with HEL have been determined (Li et al., 2003). The
contact interfaces deﬁned by these x-ray structures conﬁrm
that the epitopes recognized by all three antibodies are
essentially the same. The B-factors, which have been found
to generally correlate with motion and ﬂexibility (Micheletti
et al., 2002; Smith et al., 2003; Yuan et al., 2003; Eyal et al.,
2003; Rees et al., 2000), for all regions of the H8L10
complex were greater than those of the H26 complex,
consistent with our hypothesis that HH8 is more ﬂexible than
HH26. Our calculations show that the HH26 model
described here and the x-ray crystal structure have high
degree of similarity, with an RMS deviation of 1.03 A˚
(Fig. 9). The residues involved in hydrogen-bond formation
are also similar, and there are identical salt bridges shared by
the x-ray structure and the model (see Sinha and Smith-Gill,
2002a for a more detailed comparison). Thus, homology-
modeling combined with energy minimization of a lower
resolution structure (e.g., HH10) can predict a structure of
a closely related protein which compares well to its higher
resolution x-ray structure. Using a stringently deﬁned
criterion of deﬁning salt bridges and hydrogen bonds, we
found fewer total salt bridges and H-bonds in the energy-
minimized x-ray structure compared to the model (Sinha and
Smith-Gill, 2002a; Mohan et al., unpublished results; Sinha
et al., 2002). In the same study, the electrostatic interactions
or ion pairs not classiﬁed as salt bridges in the starting
HyHEL63-HEL structure dynamically form salt bridges of
good geometry in a large number of MD conformers during
the MD simulations (Sinha et al., 2003, unpublished results).
Therefore, a complete comparison of the model and x-ray
structure will require MD simulation of the dynamic
properties. Such a comparison is of signiﬁcance in evaluating
the modeled structures of HH8 as well as HH26, because to
date only the chimeric (H8L10) and not the native (HH8)
complex has yielded crystals suitable for x-ray analysis (Li
et al., 2003). Although many functional properties of H8L10
are similar to those of HH8, there are some signiﬁcant
differences (Lipschultz et al., 2003, unpublished results) and
for the immediate future, interpretation of structure-function
relationships for the native HH8 antibody will necessarily
FIGURE 9 Overlay of Ca backbones of the HH26-HEL model and
HH26-HEL crystal structure. Crystal structure (Li et al, 2003; PDB
accession code 1NDM) is shown in red, and the model in green. Illustration
generated using the INSIGHT II package (Accelrys, San Diego, CA).
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rely on a homology-modeled structure. Notably, the HH8
model predicts a large shift in the conformation of H2,
particularly involving residues Phe53 and Phe58. This shift
is seen in the H8L10 crystal structure and likely adds to the
high afﬁnity binding by increasing the contact area of the
hydrophobic side chains (Li et al., 2003). In addition, our
modeling and molecular dynamics data (Sinha et al., 2002;
Sinha and Smith-Gill, 2002a) suggest that the absence of
intramolecular salt links in HH8 allows this conformational
plasticity, and the even-greater shifting of H2 which is
necessary for binding to JQL without a large loss of afﬁnity.
We have also noted from the model that the interface of the
HH8 complex is the most hydrophobic among the anti-
bodies, and that the nonspeciﬁc hydrophobic contacts allow
higher afﬁnity binding with HEL mutants, e.g., higher cross-
reactivity without loss of afﬁnity or speciﬁcity for the
unmutated antigen.
CONCLUSIONS
Modeling suggests that the three-dimensional binding site
structures of the three antibodies HH8, HH10, and HH26 are
quite similar, whereas x-ray crystallography has conﬁrmed
that the binding site structures of HH10, HH26, HH63, and
the chimeric antibody H8L10 are similar. Comparison of the
modeled HH26 and the crystal structure of HH26 establishes
that homology-modeling, using as a template a moderate
structure, can predict the structure of a higher resolution
crystal structure. The speciﬁcity and cross-reactivity differ-
ences among the antibodies arise from their various numbers
of inherent speciﬁcity-determining hydrogen bonds and van
der Waals contacts as well the abilities of their CDRs to
undergo conformational rearrangements that mediate cross-
reactivity. The speciﬁcity of HH26 correlates with numerous
hydrogen bonds in its complex with HEL, and with germ-
line encoded intramolecular salt bridges that likely restrain
the binding site from assuming alternate conformations to
accommodate mutations in epitope. Fewer hydrogen bonds
and contacts, more nonspeciﬁc hydrophobic contacts, and
the absence of intramolecular salt links in HH8 confer
conformational ﬂexibility to the binding site, allowing cross-
reactivity with mutant antigen. The higher hydrophobic
surface area in the interface may at the same time mediate the
high afﬁnity of the HH8 complex (Li et al., 2003). HH10 is
intermediate in these structural and correlated functional
properties. Our results suggest that antibody cross-reactivity
correlates with combining site ﬂexibility. Restriction of
conformational ﬂexibility in antigen binding has been
demonstrated for hapten- and peptide-binding antibodies
(Wedemayer et al., 1997; Manivel et al., 2000). In the case
of the antibodies described here, higher afﬁnity is not
necessarily achieved by more ﬂexibility, but rather, in the
case of H10, an intermediate amount of ﬂexibility is optimal,
whereas in HH8 higher afﬁnity is accompanied by increased
hydrophobicity and increased ﬂexibility (Li et al., 2003).
Thus, afﬁnity maturation may select for high-afﬁnity anti-
bodies with either ‘‘lock-and-key’’ preconﬁgured binding
sites, or ‘‘preconﬁgured ﬂexibility’’ through modulation of
combining-site ﬂexibility. Detailed NMR analyses of these
antibodies would facilitate a more complete understanding of
the molecular basis of the speciﬁcity and cross-reactivity
exhibited by antibodies.
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